Source Feed: Global News - Canada
Author: Globalnews Digital
Publication Date: July 16, 2026 - 09:35
Stay informed
Unpublished Opinions
Add Alzheimer’s drug lecanemab to Canada’s public drug plans, agency says
July 16, 2026
Lecanemab is an antibody that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of the disease.
Watch the Scarborough Shooting Stars and the Ottawa BlackJacks go head-to-head in this Canadian Elite Basketball League clash from TD Place Arena in Ottawa.
July 22, 2026 - 19:30 | | CBC News - Ottawa
July 22, 2026 - 17:34 | | The Globe and Mail
July 22, 2026 - 17:33 | Maura Forrest | The Globe and Mail



Comments
Be the first to comment